Statin Tolerance Calculator
What's Your SLCO1B1 Genotype?
Select your genetic variant to see which statins are safest for you based on evidence-based guidelines.
Your Results
Recommended Statins
Avoid These Statins
Important: Genetic testing explains only about 6% of statin-related muscle symptoms. Other factors like vitamin D deficiency, thyroid issues, and medication interactions can also cause side effects. Consult your doctor before changing medications.
Select your genotype to see your personalized statin recommendations.
If you’ve been told to take a statin but stopped because of muscle pain, you’re not alone. About 7 to 29% of people on statins report muscle-related side effects-fatigue, cramps, or weakness-that make them quit. For many, it’s not just discomfort; it’s fear. What if the medicine meant to protect your heart is actually hurting your muscles? The answer might be in your genes.
Why Some People Can’t Tolerate Statins
Statins work by blocking an enzyme your liver uses to make cholesterol. But they don’t just target the liver. They circulate in your blood, and how your body handles them can vary wildly from person to person. One major reason? Genetics. The biggest genetic clue comes from a gene called SLCO1B1 a gene that codes for a protein responsible for shuttling statins into the liver. If you have a specific version of this gene-called the c.521T>C variant, or rs4149056-your body doesn’t clear certain statins efficiently. That means the drug builds up in your muscles instead of being processed safely by your liver. The result? Muscle damage. This isn’t theoretical. A 2008 study in the New England Journal of Medicine found that people with two copies of this variant (CC genotype) had a 4.5 times higher risk of severe muscle injury when taking high-dose simvastatin. Even one copy (TC genotype) doubled the risk. These aren’t rare mutations. About 15% of people of European descent carry one copy. About 1-2% carry two copies.Not All Statins Are Created Equal
Here’s the important part: this genetic risk doesn’t apply to all statins. It’s strongest for simvastatin a statin highly dependent on SLCO1B1 for liver uptake. If you have the risky gene variant and take 80mg of simvastatin, your chance of muscle damage skyrockets. But if you switch to pravastatin a statin that bypasses the SLCO1B1 transporter or fluvastatin a statin with minimal reliance on SLCO1B1, your risk drops by up to 80%. Studies show that atorvastatin a statin less affected by SLCO1B1 variants and rosuvastatin a statin with low association with SLCO1B1-related myopathy don’t show the same strong link. That’s why clinical guidelines only recommend genetic testing before prescribing simvastatin-not the others.What Does Pharmacogenomics Testing Actually Show?
Pharmacogenomics testing for statins usually means checking your SLCO1B1 status. It’s simple: a cheek swab or blood draw, sent to a lab. Results come back in about a week. The report tells you if you’re TT (low risk), TC (moderate risk), or CC (high risk). For TT carriers: You’re fine with standard statin doses. No changes needed. For TC carriers: Avoid high-dose simvastatin (80mg). Lower doses or alternative statins are safer. For CC carriers: Don’t take simvastatin 80mg at all. Even 40mg may be risky. Switch to pravastatin, fluvastatin, or another statin not affected by this gene. These recommendations come from the Clinical Pharmacogenetics Implementation Consortium (CPIC) a group that creates evidence-based guidelines for genetic testing in drug use, and they’re backed by major medical groups like the American College of Cardiology.
Does Testing Actually Help People Stay on Statins?
Here’s where it gets messy. Some studies say yes. A 2021 survey at Mayo Clinic found that 78% of patients who had previously quit statins due to muscle pain were able to restart them successfully after genetic testing guided their choice. One woman, 54, had severe muscle pain on simvastatin. Her test showed CC genotype. She switched to pravastatin. Her LDL dropped from 168 to 92-without pain. But other studies say no. A 2020 trial published in JAMA Network Open gave SLCO1B1 results to doctors and patients. Did people stick with statins better? No. Did muscle pain go down? Not significantly. Why? Because muscle symptoms aren’t always genetic. Age, diabetes, thyroid problems, vitamin D deficiency, and even intense exercise can trigger statin-related muscle pain. SLCO1B1 explains only about 6% of the risk. That’s why the American College of Cardiology doesn’t recommend testing for everyone. They say: Only consider it if you’ve already had trouble with statins and want to try again.Who Should Get Tested?
You might benefit from pharmacogenomics testing if:- You had muscle pain on a statin and stopped taking it
- You’re considering restarting a statin after quitting due to side effects
- You’re about to start simvastatin and have a family history of statin intolerance
- Your doctor is unsure which statin to pick after previous failures
Cost, Coverage, and Access
As of 2023, standalone SLCO1B1 testing costs between $150 and $400 out-of-pocket. Insurance coverage is spotty. Only about 28% of commercial insurers in the U.S. covered it in 2022. Medicare rarely pays unless it’s part of a broader pharmacogenomic panel tied to a specific clinical scenario. Some labs, like Mayo Clinic Laboratories a leading provider of clinical pharmacogenomic testing and ARUP Laboratories a national reference lab offering comprehensive PGx panels, provide detailed reports with clear dosing advice. Others, especially direct-to-consumer tests, just give raw data-no interpretation. Many doctors still feel unprepared. A 2021 survey found that 34% of primary care physicians didn’t know how to interpret the results. That’s why some hospitals are building clinical decision tools into their electronic health records. If your doctor prescribes simvastatin and your SLCO1B1 status is in your chart, the system can warn them: “High risk. Consider alternative.”What’s Next for Genetic Testing and Statins?
Scientists are now looking beyond SLCO1B1. Other genes-like ABCB1 a gene involved in drug efflux from cells, GATM a gene linked to creatine metabolism and muscle energy, and SOAT1 a gene recently linked to statin muscle symptoms with strong statistical significance-are showing up in newer studies. One 2023 study combined 15 genetic markers into a single score. It improved prediction accuracy from 58% to 67%. The Statin Pharmacogenomics Implementation Consortium a national effort to standardize testing across U.S. hospitals is launching in 2023, aiming to get testing into 50 hospitals by 2025. The goal? Make it routine-not for everyone, but for those who need it most.Bottom Line: Is It Worth It?
If you’ve quit a statin because of muscle pain, genetic testing could be your lifeline. It won’t explain every case-but for some, it’s the key to getting back on a heart-protecting medication without pain. Don’t ask for testing unless you’ve had trouble. Don’t assume it’s a magic fix. But if you’ve been stuck between high cholesterol and muscle pain, talk to your doctor. Ask: “Could my genes be making statins harder to tolerate?” The science is ready. The tools are here. The question is no longer whether genetics matter-it’s whether your care team knows how to use them.Can pharmacogenomics testing prevent statin side effects?
Testing doesn’t prevent side effects, but it can help avoid the ones most likely to happen based on your genes. For example, if you have the SLCO1B1 CC genotype, switching from simvastatin to pravastatin can cut your risk of muscle damage by up to 80%. It doesn’t guarantee you won’t have symptoms, but it removes the biggest genetic risk factor.
Is genetic testing for statins covered by insurance?
Only about 28% of commercial insurers in the U.S. cover SLCO1B1 testing as of 2022. Medicare rarely pays unless it’s part of a broader pharmacogenomic panel tied to a specific clinical need. Out-of-pocket costs range from $150 to $400. Some hospital systems offer testing at reduced rates or as part of research programs.
Do I need to get tested before starting any statin?
No. Current guidelines only recommend testing if you’ve had muscle symptoms on a statin and want to try again. If you’ve never had side effects, there’s no benefit to testing upfront. The risk is low enough that most people tolerate statins fine without genetic screening.
What if my test shows a high-risk genotype but I still get muscle pain on a different statin?
That’s common. SLCO1B1 explains only about 6% of statin-related muscle symptoms. Other causes include low vitamin D, thyroid issues, kidney disease, intense exercise, or interactions with other medications. If you still have pain, your doctor should check for these other factors before giving up on statins entirely.
Can I get tested through my regular doctor?
Some primary care doctors can order the test, but many aren’t familiar with interpreting the results. Cardiologists and pharmacists are more likely to have experience. If your doctor isn’t comfortable, ask for a referral to a lipid specialist or clinical pharmacist trained in pharmacogenomics. Labs like Mayo Clinic and ARUP also offer physician consultation services with their reports.
Are there other genes besides SLCO1B1 that affect statin tolerance?
Yes. Genes like ABCB1, GATM, and SOAT1 have shown associations with statin muscle symptoms in recent studies. But none are as well-established or clinically actionable as SLCO1B1. Testing for these genes is still experimental and not part of standard guidelines. For now, SLCO1B1 remains the only gene with clear, evidence-based recommendations.